Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15118803 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia
Conditions: Schizophrenia;   Negative Symptoms;   Cognitive Impairments
Intervention: Drug: Pergolide (drug)

Indicates status has not been verified in more than two years